Qventus, a leading provider of AI-based care automation software for health systems, has secured a $105 million investment in a Series D funding round. The round was led by global investment firm KKR, with additional participation from Bessemer Venture Partners and strategic investors including Northwestern Medicine, HonorHealth, and Allina Health.
Company Overview:
Founded in 2012, Qventus has developed an AI-first care operations automation platform deployed across leading health systems in both inpatient and outpatient settings. The company’s solutions aim to alleviate administrative burdens, enhance team productivity, and improve patient care delivery.
Use of Funds:
The new capital will accelerate the development and commercialization of Qventus’ AI Operational Assistants platform, extending its capabilities across various care settings. This includes enhancing existing solutions like Surgical Growth and Inpatient Capacity, as well as introducing new AI-driven tools to support clinical operations.
Impact and Achievements:
In the past year, Qventus’ Inpatient Capacity solution eliminated over 36,000 excess days for health system partners, saving millions of dollars and creating capacity to serve more patients. Additionally, the Surgical Growth solution generated $95 million in annualized contribution margin in 2024 through Qventus-enabled cases, touching more than 500 million surgeries and driving a 35% increase in robotic cases.
This investment underscores the growing interest in AI-driven solutions to enhance efficiency and quality in healthcare operations.
